The molecular etiology and treatment of glucocorticoid-induced osteoporosis

The molecular etiology and treatment of glucocorticoid-induced osteoporosis

Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, accounting for 20% of osteoporosis diagnoses. Using glucocorticoids for >6 months leads to osteoporosis in 50% of patients, resulting in an increased risk of fracture and death. Osteoblasts, osteocytes,...

Full description

Bibliographic Details
Main Authors: Cheng-Huan Peng, Wen-Ying Lin, Kuang-Ting Yeh, Ing-Ho Chen, Wen-Tien Wu, Ming-Der Lin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Tzu-Chi Medical Journal
Subjects:
bone remodeling
glucocorticoid
osteoblast
osteoclast
secondary osteoporosis
Online Access:http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=3;spage=212;epage=223;aulast=Peng

Internet

http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2021;volume=33;issue=3;spage=212;epage=223;aulast=Peng

Similar Items